Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (31-40 of 596) with videos related to

Pageof 60
Sort By:
Oncotarget|September 30, 2024
<i>UBA1</i> dysfunction in VEXAS and cancerMaki Sakuma, Torsten Haferlach, Wencke Walter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implicationsGuido Marcucci, Torsten Haferlach, Hartmut Döhner
Current Opinion in Oncology|September 1, 2010
Molecular genetics in acute myeloid leukemiaUlrike Bacher, Susanne Schnittger, Torsten Haferlach
Cancer Treatment Reviews|June 24, 2010
Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignanciesUlrike Bacher, Alexander Kohlmann, Torsten Haferlach
Handbook of Experimental Pharmacology|August 21, 2022
Precision Medicine in Therapy of Non-solid CancerInes Schmidts, Torsten Haferlach, Gregor Hoermann
Briefings in Functional Genomics & Proteomics|May 29, 2009
Perspectives of gene expression profiling for diagnosis and therapy in haematological malignanciesUlrike Bacher, Alexander Kohlmann, Torsten Haferlach
British Journal of Haematology|April 7, 2009
Current status of gene expression profiling in the diagnosis and management of acute leukaemiaUlrike Bacher, Alexander Kohlmann, Torsten Haferlach
The New England Journal of Medicine|December 14, 2016
Cord-Blood Transplantation in Patients with Minimal Residual DiseaseChristopher S Hourigan, Torsten Haferlach, Peter Hokland
Cancer|June 24, 2010
Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical dataWolfgang Kern, Claudia Haferlach, Susanne Schnittger, et al.
Haematologica|June 24, 2017
Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genesManja Meggendorfer, Claudia Haferlach, Wolfgang Kern, et al.
Pageof 60

Showing results (31-40 of 596) with videos related to

Sort By:
Pageof 60
Oncotarget|September 30, 2024
<i>UBA1</i> dysfunction in VEXAS and cancerMaki Sakuma, Torsten Haferlach, Wencke Walter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implicationsGuido Marcucci, Torsten Haferlach, Hartmut Döhner
Current Opinion in Oncology|September 1, 2010
Molecular genetics in acute myeloid leukemiaUlrike Bacher, Susanne Schnittger, Torsten Haferlach
Cancer Treatment Reviews|June 24, 2010
Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignanciesUlrike Bacher, Alexander Kohlmann, Torsten Haferlach
Handbook of Experimental Pharmacology|August 21, 2022
Precision Medicine in Therapy of Non-solid CancerInes Schmidts, Torsten Haferlach, Gregor Hoermann
Briefings in Functional Genomics & Proteomics|May 29, 2009
Perspectives of gene expression profiling for diagnosis and therapy in haematological malignanciesUlrike Bacher, Alexander Kohlmann, Torsten Haferlach
British Journal of Haematology|April 7, 2009
Current status of gene expression profiling in the diagnosis and management of acute leukaemiaUlrike Bacher, Alexander Kohlmann, Torsten Haferlach
The New England Journal of Medicine|December 14, 2016
Cord-Blood Transplantation in Patients with Minimal Residual DiseaseChristopher S Hourigan, Torsten Haferlach, Peter Hokland
Cancer|June 24, 2010
Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical dataWolfgang Kern, Claudia Haferlach, Susanne Schnittger, et al.
Haematologica|June 24, 2017
Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genesManja Meggendorfer, Claudia Haferlach, Wolfgang Kern, et al.
Pageof 60